Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.710
-0.140 (-2.89%)
At close: Mar 10, 2025, 4:00 PM
4.716
+0.006 (0.12%)
Pre-market: Mar 11, 2025, 7:00 AM EST
Vanda Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Vanda Pharmaceuticals stock have an average target of 16.5, with a low estimate of 13 and a high estimate of 20. The average target predicts an increase of 250.32% from the current stock price of 4.71.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vanda Pharmaceuticals stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $20 | Strong Buy | Maintains | $18 → $20 | +324.63% | Feb 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +282.17% | Feb 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +282.17% | Jan 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +282.17% | Jan 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +282.17% | Dec 23, 2024 |
Financial Forecast
Revenue This Year
227.31M
from 198.77M
Increased by 14.36%
Revenue Next Year
328.52M
from 227.31M
Increased by 44.53%
EPS This Year
-1.14
from -0.33
EPS Next Year
0.01
from -1.14
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 236.3M | 365.9M | 398.1M |
| Avg | 227.3M | 328.5M | 306.1M |
| Low | 214.2M | 291.8M | 216.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 18.9% | 61.0% | 21.2% |
| Avg | 14.4% | 44.5% | -6.8% |
| Low | 7.8% | 28.4% | -34.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.98 | 0.58 | 0.35 |
| Avg | -1.14 | 0.01 | 0.34 |
| Low | -1.23 | -0.74 | 0.32 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | 4,993.0% |
| Avg | - | - | 4,847.5% |
| Low | - | - | 4,653.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.